logo-loader
viewArcadia Biosciences Inc

Arcadia Biosciences shares slump after organizing $14mln direct offering

The agricultural engineering company hopes to raise US$13.83mln via the deal

crops
Arcadia shares are trading lower in early afternoon trade

Arcadia Biosciences Inc (Nasdaq: RKDA), an agricultural engineering company, is orchestrating a direct offering priced at the market.

It has entered into definitive agreements with several institutional investors for the purchase of 1,392,345 shares of its common stock at a purchase price per share of US$9.93. The deal will result in gross proceeds of about US$13.83mln.

In the wake of the announcement, Arcadia shares fell 9% to US$9.12 in early afternoon trade.

Based in Davis, California, Arcadia is an agricultural technology company that uses genetic engineering to increase farmers’ crop yields.

Arcadia hopes to use the money raised from the offering to scale up its GoodWheat Resistant Starch wheat production as well as to pay for its more general business needs.

Arcadia also agreed to issue to its investors unregistered warrants to purchase up to 1,392,345 shares of common stock, at a purchase price per warrant of US$0.125 for gross proceeds of about US$0.17m.

The closing of its offering is set to take place on June 14 and the deal will be subject to the usual closing conditions.

 

Quick facts: Arcadia Biosciences Inc

Price: 5.06 USD

NASDAQ:RKDA
Market: NASDAQ
Market Cap: $43.6 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read